NovaXS Biotech announced that it unveiled the new prototype for its needle-free injection therapy smart medical device.
Formed at the University of California, Berkeley, NovaXS designed its patent-pending Telosis technology to administer a narrow stream of medication without a needle in 0.3 seconds and to analyze injection data to allow for smarter health decisions.
The company said in a news release that its technology represents the world’s first remote medication and self-administration monitoring platform as an easy and painless alternative for at-home drug delivery.
Article By: Sean Whooley
Featured In: Mass Device | Drug Delivery Business | Medical Device Source
To read to the full article please go to: